دورية أكاديمية
Global miRNA expression reveals novel nuclear and mitochondrial interactions in Type 1 diabetes mellitus.
| العنوان: | Global miRNA expression reveals novel nuclear and mitochondrial interactions in Type 1 diabetes mellitus. |
|---|---|
| المؤلفون: | Ferraz RS; Laboratory of Human and Medical Genetics, Graduate Program in Genetics and Molecular Biology, Federal University of Para, Belem, PA, Brazil., Santos LCB; Laboratory of Human and Medical Genetics, Graduate Program in Genetics and Molecular Biology, Federal University of Para, Belem, PA, Brazil., da-Silva-Cruz RL; Laboratory of Human and Medical Genetics, Graduate Program in Genetics and Molecular Biology, Federal University of Para, Belem, PA, Brazil., Braga-da-Silva CH; Laboratory of Human and Medical Genetics, Graduate Program in Genetics and Molecular Biology, Federal University of Para, Belem, PA, Brazil., Magalhães L; Laboratory of Human and Medical Genetics, Graduate Program in Genetics and Molecular Biology, Federal University of Para, Belem, PA, Brazil., Ribeiro-Dos-Santos A; Laboratory of Human and Medical Genetics, Graduate Program in Genetics and Molecular Biology, Federal University of Para, Belem, PA, Brazil., Vidal A; Laboratory of Human and Medical Genetics, Graduate Program in Genetics and Molecular Biology, Federal University of Para, Belem, PA, Brazil.; Instituto Tecnológico Vale Desenvolvimento Sustentável Vale, Institute of Technology, Belem, PA, Brazil., Vinasco-Sandoval T; Laboratoire de Génomique et Radiobiologie de la Kératinopoïèse, Institut de Biologie François Jacob, CEA/DRF/IRCM, Evry, France., Reis-das-Mercês L; Laboratory of Human and Medical Genetics, Graduate Program in Genetics and Molecular Biology, Federal University of Para, Belem, PA, Brazil., Sena-Dos-Santos C; Laboratory of Human and Medical Genetics, Graduate Program in Genetics and Molecular Biology, Federal University of Para, Belem, PA, Brazil., Pereira AL; Medical School, Federal University of Para, Altamira, PA, Brazil., Silva LSD; Endocrinology Research Center, Joao de Barros Barreto University Hospital, Federal University of Para, Belem, PA, Brazil., de Melo FTC; Endocrinology Research Center, Joao de Barros Barreto University Hospital, Federal University of Para, Belem, PA, Brazil., de Souza ACCB; Endocrinology Research Center, Joao de Barros Barreto University Hospital, Federal University of Para, Belem, PA, Brazil., Leal VSG; Endocrinology Research Center, Joao de Barros Barreto University Hospital, Federal University of Para, Belem, PA, Brazil., de Figueiredo PBB; Endocrinology Research Center, Joao de Barros Barreto University Hospital, Federal University of Para, Belem, PA, Brazil., Neto JFA; Endocrinology Research Center, Joao de Barros Barreto University Hospital, Federal University of Para, Belem, PA, Brazil., de Moraes LV; Endocrinology Research Center, Joao de Barros Barreto University Hospital, Federal University of Para, Belem, PA, Brazil., de Lemos GN; Endocrinology Research Center, Joao de Barros Barreto University Hospital, Federal University of Para, Belem, PA, Brazil., de Queiroz NNM; Endocrinology Research Center, Joao de Barros Barreto University Hospital, Federal University of Para, Belem, PA, Brazil., Felício KM; Endocrinology Research Center, Joao de Barros Barreto University Hospital, Federal University of Para, Belem, PA, Brazil., Cavalcante GC; Laboratory of Human and Medical Genetics, Graduate Program in Genetics and Molecular Biology, Federal University of Para, Belem, PA, Brazil., Ribeiro-Dos-Santos Â; Laboratory of Human and Medical Genetics, Graduate Program in Genetics and Molecular Biology, Federal University of Para, Belem, PA, Brazil.; Oncology Research Center, Graduate Program in Oncology and Medical Sciences, Joao de Barros Barreto University Hospital, Federal University of Para, Belem, PA, Brazil., Felício JS; Endocrinology Research Center, Joao de Barros Barreto University Hospital, Federal University of Para, Belem, PA, Brazil. |
| المصدر: | Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2022 Nov 24; Vol. 13, pp. 1033809. Date of Electronic Publication: 2022 Nov 24 (Print Publication: 2022). |
| نوع المنشور: | Journal Article; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: [Lausanne : Frontiers Research Foundation] |
| مواضيع طبية MeSH: | Diabetes Mellitus, Type 1*/genetics , MicroRNAs*/genetics , MicroRNAs*/metabolism, Humans ; High-Throughput Nucleotide Sequencing ; Mitochondria/genetics ; Mitochondria/metabolism ; Biomarkers |
| مستخلص: | Background: Considering the potential role of miRNAs as biomarkers and their interaction with both nuclear and mitochondrial genes, we investigated the miRNA expression profile in type 1 diabetes (T1DM) patients, including the pathways in which they are involved considering both nuclear and mitochondrial functions. Methods: We analyzed samples of T1DM patients and control individuals (normal glucose tolerance) by high throughput miRNA sequencing (miRNome). Next, five miRNAs - hsa-miR-26b-5p , hsa-let-7i-5p , hsa-miR-143-3p , hsa-miR-501-3p and hsa-miR-100-5p - were validated by RT-qPCR. The identification of target genes was extracted from miRTarBase and mitoXplorer database. We also performed receiver operating characteristic (ROC) curves and miRNAs that had an AUC > 0.85 were considered potential biomarkers. Results: Overall, 41 miRNAs were differentially expressed in T1DM patients compared to control. Hsa-miR-21-5p had the highest number of predicted target genes and was associated with several pathways, including insulin signaling and apoptosis. 34.1% (14/41) of the differentially expressed miRNAs also targeted mitochondrial genes, and 80.5% (33/41) of them targeted nuclear genes involved in the mitochondrial metabolism. All five validated miRNAs were upregulated in T1DM. Among them, hsa-miR-26b-5p showed AUC>0.85, being suggested as potential biomarker to T1DM. Conclusion: Our results demonstrated 41 DE miRNAs that had a great accuracy in discriminating T1DM and control group. Furthermore, we demonstrate the influence of these miRNAs on numerous metabolic pathways, including mitochondrial metabolism. Hsa-miR-26b-5p and hsa-miR-21-5p were highlighted in our results, possibly acting on nuclear and mitochondrial dysfunction and, subsequently, T1DM dysregulation. Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2022 Ferraz, Santos, da-Silva-Cruz, Braga-da-Silva, Magalhães, Ribeiro-dos-Santos, Vidal, Vinasco-Sandoval, Reis-das-Mercês, Sena-dos-Santos, Pereira, Silva, Melo, Souza, Leal, Figueiredo, Neto, Moraes, Lemos, Queiroz, Felício, Cavalcante, Ribeiro-dos-Santos and Felício.) |
| References: | Biosci Rep. 2021 Jan 29;41(1):. (PMID: 33439992) Front Endocrinol (Lausanne). 2018 Aug 03;9:402. (PMID: 30123182) Nat Rev Endocrinol. 2013 Sep;9(9):513-21. (PMID: 23629540) Oxid Med Cell Longev. 2014;2014:960362. (PMID: 24683439) Int J Mol Sci. 2020 Mar 06;21(5):. (PMID: 32155913) Bioinformatics. 2013 Jan 1;29(1):15-21. (PMID: 23104886) Antioxid Redox Signal. 2007 Mar;9(3):343-53. (PMID: 17184177) Mol Metab. 2019 Sep;27S:S122-S128. (PMID: 31500823) Mol Biosyst. 2016 Feb;12(2):477-9. (PMID: 26661513) J Clin Lab Anal. 2016 Sep;30(5):727-31. (PMID: 26892629) Bioinformatics. 2015 Jan 15;31(2):166-9. (PMID: 25260700) Diabetologia. 2015 Oct;58(10):2298-306. (PMID: 26141787) Redox Biol. 2021 May;41:101910. (PMID: 33667993) Cytokine. 2012 Jul;59(1):86-93. (PMID: 22513191) Mol Cell Endocrinol. 2019 Jun 15;490:1-14. (PMID: 30926524) Bone. 2014 Jan;58:33-41. (PMID: 24120383) J Clin Invest. 2021 Sep 15;131(18):. (PMID: 34343133) Clin Diabetes. 2015 Apr;33(2):97-111. (PMID: 25897193) J Clin Endocrinol Metab. 2018 Apr 1;103(4):1320-1329. (PMID: 29370422) Front Cell Dev Biol. 2021 Mar 18;9:630248. (PMID: 33816476) FASEB J. 2015 Oct;29(10):4374-83. (PMID: 26148972) Nucleic Acids Res. 2020 Jan 24;48(2):605-632. (PMID: 31799603) OMICS. 2012 May;16(5):284-7. (PMID: 22455463) Bioinformatics. 2014 Aug 1;30(15):2114-20. (PMID: 24695404) Genome Biol. 2014;15(12):550. (PMID: 25516281) Diabetes Care. 2012 Apr;35(4):768-73. (PMID: 22374641) Bosn J Basic Med Sci. 2017 Aug 20;17(3):183-193. (PMID: 28368239) Aging Cell. 2021 Sep;20(9):e13443. (PMID: 34363732) Diabetes Metab Syndr. 2019 Jan - Feb;13(1):364-372. (PMID: 30641727) Nature. 2004 Nov 11;432(7014):226-30. (PMID: 15538371) Int J Mol Sci. 2019 Dec 19;21(1):. (PMID: 31861649) J Biol Chem. 2009 Oct 2;284(40):27090-100. (PMID: 19654321) Endocr Connect. 2017 Nov;6(8):773-790. (PMID: 28986402) Genome Res. 2003 Nov;13(11):2498-504. (PMID: 14597658) Eur J Pharmacol. 2021 Jul 5;902:174081. (PMID: 33901463) Mitochondrion. 2013 Nov;13(6):762-71. (PMID: 23665486) Nucleic Acids Res. 2011 Jan;39(Database issue):D163-9. (PMID: 21071411) World J Diabetes. 2020 Jan 15;11(1):13-25. (PMID: 31938470) Exp Mol Med. 2018 Dec 5;50(12):1-14. (PMID: 30518745) Cell Immunol. 2010;260(2):70-4. (PMID: 19954774) Int J Clin Exp Med. 2008;1(2):98-116. (PMID: 19079665) Acta Med Okayama. 2016 Jun;70(3):151-8. (PMID: 27339203) Pediatric Health Med Ther. 2022 Jun 22;13:243-256. (PMID: 35769766) |
| فهرسة مساهمة: | Keywords: miRNAs; miRnome; mitochondrial target; nuclear target; type 1 diabetes |
| المشرفين على المادة: | 0 (MicroRNAs) 0 (Biomarkers) |
| تواريخ الأحداث: | Date Created: 20221212 Date Completed: 20221214 Latest Revision: 20230126 |
| رمز التحديث: | 20230127 |
| مُعرف محوري في PubMed: | PMC9731375 |
| DOI: | 10.3389/fendo.2022.1033809 |
| PMID: | 36506063 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1664-2392 |
|---|---|
| DOI: | 10.3389/fendo.2022.1033809 |